Boston Bio Systems Ltd.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve Intimation of Board Meeting pursuant to Regulation 29(1)(a) of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015 1) Consider and approve unaudited Financial Results of the Company for the quarter and half year ended September 30, 2024. 2) Consider any other matter which the Board deems fit.